Literature DB >> 6293053

In vivo identification of the transforming gene product of simian sarcoma virus.

K C Robbins, S G Devare, E P Reddy, S A Aaronson.   

Abstract

Simian sarcoma virus (SSV) deletion mutants were constructed from a molecular clone containing the entire infectious provirus. Transfection analysis of these mutants localized the SSV transforming gene to a small region of the viral genome encompassing its cell-derived sequence (v-sis). Antiserum to a peptide synthesized on the basis of the predicted amino acid sequence of the SSV transforming gene detected a 28,000-dalton protein that was specifically expressed in SSV transformed cells and that corresponded in size to that predicted from the v-sis coding sequence. The v-sis gene product designated p28sis was not a phosphoprotein, nor did it possess detectable protein kinase activity. These findings distinguish p28sis from a number of other retroviral onc proteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293053     DOI: 10.1126/science.6293053

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  24 in total

1.  Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system.

Authors:  N Giese; M May-Siroff; W J LaRochelle; K van Wyke Coelingh; S A Aaronson
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

2.  Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity.

Authors:  W J LaRochelle; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

3.  Synthesis and secretion of proteins resembling platelet-derived growth factor by human glioblastoma and fibrosarcoma cells in culture.

Authors:  P Pantazis; P G Pelicci; R Dalla-Favera; H N Antoniades
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  New human transforming genes detected by a tumorigenicity assay.

Authors:  O Fasano; D Birnbaum; L Edlund; J Fogh; M Wigler
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

5.  Deletion of Alu sequences in the fifth c-sis intron in individuals with meningiomas.

Authors:  M Smidt; I Kirsch; L Ratner
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

Review 7.  Karyotypic progression in human tumors.

Authors:  S R Wolman
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  Assignment of the Ly-6--Ril-1--Sis--H-30--Pol-5/Xmmv-72--Ins-3--Krt-1--Int-1 --Gdc-1 region to mouse chromosome 15.

Authors:  D Meruelo; A Rossomando; S Scandalis; P D'Eustachio; R E Fournier; D R Roop; D Saxe; C Blatt; M N Nesbitt
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

9.  Primary structure of the human fgr proto-oncogene product p55c-fgr.

Authors:  S Katamine; V Notario; C D Rao; T Miki; M S Cheah; S R Tronick; K C Robbins
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

Review 10.  Oncogenes: clues to carcinogenesis.

Authors:  C R Bartram
Journal:  Eur J Pediatr       Date:  1984-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.